Where does Alex Kolicich work?

Alex Kolicich is Founding Partner at 8VC and Board director at Senti Biosciences and Board director at Alloy Therapeutics, Inc. and Board director at Tradewing.

What check size does Alex Kolicich write?

Alex Kolicich typically writes checks of $3M – $30M.

What boards does Alex Kolicich sit on?

Alex Kolicich holds tracked board seats at Adentro, Alloy Therapeutics, Inc., Dren Bio, Hexagon Bio, Indio, Orca Bio, Qualia, Senti Biosciences, Tradewing.

What companies has Alex Kolicich invested in?

Investments tracked here include AppDirect, C2FO, Helion Energy, Edra, Kos.ai, Palantir, Quince, Saris AI.

Where did Alex Kolicich go to school?

Alex Kolicich studied at University of Waterloo (B.SE, Software Engineering); University of Toronto (MA, Economics).

Does Alex Kolicich lead rounds?

Yes — Alex Kolicich has led 3 tracked investments.

Alex Kolicich

InvestorFounder

Founding Partner at 8VC · Board director at Senti Biosciences · Board director at Alloy Therapeutics, Inc. · Board director at Tradewing

South San Francisco, California

Writes $3M – $30M checks · typically $16.5M

About

Alex Kolicich applies computer‑science and engineering expertise to technical investing in enterprise, infrastructure and AI, emphasizing Defense Tech and publishing H1/H2 market letters synthesizing macro, venture flows and AI‑platform shifts.

Likely email· guessed from name + firm domain, not firm-published

a•••@8vc.comreveal100% confident

Invests in

AI & Machine LearningBiotechData & InfrastructureDeep TechDefense TechEnterprise SoftwareHealthtechLogistics & Supply Chain

Beyond investing

Communities: Kolicich has expressed a commitment to San Francisco and a preference for builders who stay to improve their communities.
More: Kolicich publishes quarterly reports on the state of the venture capital market on his website. At Google Research he worked on Google Street View before and during its launch, and earlier worked on the development and launch of Google Checkout.

From Alex's own website — common ground for a warm intro.

Board director at Senti Biosciences

Intro paths

→

In turn, Alex can intro founders to Senti Biosciences's investors below.

Senti Biosciences's investors · 11

8VCAustin · $100K – $50M checks · since 2018 Evolution VC PartnersNew York Flucas VenturesJupiter · $100K – $5M checks Lifeforce CapitalChevy Chase · $500K – $5M checks Lux CapitalNew York · $100K – $100M checks Menlo VenturesSan Francisco · $1M – $20M checks National Institutes of Health (NIH)since 2018 National Science FoundationAlexandria · since 2018 NEA SecondaryTimonium · since 2026 New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2018 NSG VenturesSingapore

Co-founders at Senti Biosciences

Tim LuCo-Founder and Chief Executive Officer

Philip LeeExecutive Officer

Board director at Alloy Therapeutics, Inc.

Intro paths

→

In turn, Alex can intro founders to Alloy Therapeutics, Inc.'s investors below.

Alloy Therapeutics, Inc.'s investors · 5

82VSBoston 8VCAustin · $100K – $50M checks · since 2026 JIC Venture Growth InvestmentsTokyo MC Healthcare VenturesCambridge · since 2026 Mission BiocapitalSan Francisco · $500K checks · since 2026

Co-founders at Alloy Therapeutics, Inc.

Errik B. AndersonExecutive Officer, Director

Board director at Tradewing

Intro paths

→

In turn, Alex can intro founders to Tradewing's investors below.

Tradewing's investors · 1

8VCAustin · $100K – $50M checks · since 2020

Co-founders at Tradewing

Eric MeiselExecutive Officer, Director

Doron Roberts-KedesExecutive Officer, Director

Experience

8VCFounding Partnercurrent2015 — present
The C100Charter Membercurrent2017 — presentSan Francisco Bay Area
Blend LabsAdvisorcurrent2014 — present
Formation 8Partner2014 — 2015San Francisco Bay Area
AppDirectInvestor and Advisor2014San Francisco Bay Area
Helion EnergyInvestor2014
C2FOBoard Observer2013 — 2014Kansas City Metropolitan Area
Mithril Capital ManagementPrincipal2012 — 2014San Francisco Bay Area
Clarium Capital ManagementPM, Vice President, Research & Trading2009 — 2012San Francisco Bay Area
Palantir TechnologiesAdvisor2007 — 2010Palo Alto
Clarium Capital ManagementQuantitative Analyst2008
Clarium Capital ManagementQuantitative Analyst2007
GoogleEngineering2006 — 2007

Education

University of WaterlooB.SE, Software Engineering2003 — 2008
University of TorontoMA, Economics2008 — 2009

Skills & more

Bloomberg7VBA1Java4C++4SQL1R2Django3Python1Trading25Economics16Hedge Funds9Venture Capital19

+12 more

ResearchStatisticsMacroeconomicsFX OptionsInvestmentsValuationDerivativesSoftware EngineeringPrivate EquityRisk ManagementStart-upsAnalysis

Languages Serbian

From Alex's professional profile.

Deals · 5

Alloy Therapeutics, Inc.Board seat

via 8VC · filed Apr 2026 · $40M raise

Dren BioBoard seat

via 8VC · filed Mar 2022 · $80M raise

TradewingBoard seat

via 8VC · filed Apr 2020 · $7.1M raise

Senti BiosciencesBoard seat

via 8VC · filed Feb 2018 · $53.4M raise

IndioBoard seat

via 8VC · filed Jan 2018 · $8.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Led

AppDirectC2FOHelion Energy

Board seats

Adentro Hexagon Bio Orca Bio Qualia

Investor

EdraKos.aiPalantir QuinceSaris AI

Sources: the firm's website · SEC Form D filings.

Colleagues at 8VC

Adrienne Alexander

Operations at 8VC

Alex McLane

Investment Team at 8VC

Alex Moore

Investment Team at 8VC

Portfolio Support at 8VC

Ava Eitzen

Portfolio Support at 8VC

Bela Becerra

Investment Team at 8VC

Network10

Alex MooreScout

Investment Team at 8VC

Arthur JamesScout

Advisor at 8VC

Paul GrossingerScout

Co-founder & General Partner at Gaingels

Seetharam VenkateshScout

Investment Team at 8VC

Doug Benowitz

Principal at Colle Capital Partners

Eric Scott

Advisor at 8VC

Fabian Hansen

Founder and General Partner at Presight Capital

Francisco Gimenez

Investment Team at 8VC

Investors connected to Alex in public investor directories — a warm-intro map.

Frequently asked questions

Who is Alex Kolicich?: Alex Kolicich applies computer‑science and engineering expertise to technical investing in enterprise, infrastructure and AI, emphasizing Defense Tech and publishing H1/H2 market letters synthesizing macro, venture flows and AI‑platform shifts.
Where does Alex Kolicich work?: Alex Kolicich is Founding Partner at 8VC and Board director at Senti Biosciences and Board director at Alloy Therapeutics, Inc. and Board director at Tradewing.
What does Alex Kolicich invest in?: Alex Kolicich invests in AI & Machine Learning, Biotech, Data & Infrastructure, Deep Tech, Defense Tech, Enterprise Software, Healthtech, Logistics & Supply Chain.
What check size does Alex Kolicich write?: Alex Kolicich typically writes checks of $3M – $30M.
What boards does Alex Kolicich sit on?: Alex Kolicich holds tracked board seats at Adentro, Alloy Therapeutics, Inc., Dren Bio, Hexagon Bio, Indio, Orca Bio, Qualia, Senti Biosciences, Tradewing.
What companies has Alex Kolicich invested in?: Investments tracked here include AppDirect, C2FO, Helion Energy, Edra, Kos.ai, Palantir, Quince, Saris AI.
Where did Alex Kolicich go to school?: Alex Kolicich studied at University of Waterloo (B.SE, Software Engineering); University of Toronto (MA, Economics).
Does Alex Kolicich lead rounds?: Yes — Alex Kolicich has led 3 tracked investments.